Neurociencias
Departamento
Universidad de Extremadura
Badajoz, EspañaPublicaciones en colaboración con investigadoras/es de Universidad de Extremadura (17)
2023
-
Changes in Liver Lipidomic Profile in G2019S-LRRK2 Mouse Model of Parkinson’s Disease
Cells, Vol. 12, Núm. 5
2022
-
Delay of EGF-Stimulated EGFR Degradation in Myotonic Dystrophy Type 1 (DM1)
Cells, Vol. 11, Núm. 19
-
The parkinsonian LRRK2 R1441G mutation shows macroautophagy-mitophagy dysregulation concomitant with endoplasmic reticulum stress
Cell Biology and Toxicology, Vol. 38, Núm. 5, pp. 889-911
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2019
-
Impaired Mitophagy and Protein Acetylation Levels in Fibroblasts from Parkinson’s Disease Patients
Molecular Neurobiology, Vol. 56, Núm. 4, pp. 2466-2481
2018
-
Acetylome in human fibroblasts from Parkinson’s disease patients
Frontiers in Cellular Neuroscience, Vol. 12
-
Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis
Schizophrenia Research, Vol. 193, pp. 188-196
-
Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis
Journal of Psychopharmacology, Vol. 32, Núm. 6, pp. 702-710
2017
-
Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients
European Neuropsychopharmacology, Vol. 27, Núm. 7, pp. 647-656
2016
-
A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project
International Journal of Neuropsychopharmacology, Vol. 19, Núm. 4
-
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356
Autophagy
-
Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: Role of dopamine, serotonin and glutamate candidate genes
Pharmacogenomics Journal, Vol. 16, Núm. 5, pp. 439-445
-
Pompe disease and autophagy: Partners in crime, or cause and consequence?
Current Medicinal Chemistry, Vol. 23, Núm. 21, pp. 2275-2285
2014
2013
-
The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway
Cellular and Molecular Life Sciences, Vol. 70, Núm. 1, pp. 121-136
2012
-
The MAPK1/3 pathway is essential for the deregulation of autophagy observed in G2019S LRRK2 mutant fibroblasts
Autophagy, Vol. 8, Núm. 10, pp. 1537-1539
2010
-
An organotypic culture model to study nigro-striatal degeneration
Journal of Neuroscience Methods, Vol. 188, Núm. 2, pp. 205-212